Inflammation and dialysate quality

Hemodialysis International

Volumn 10, Issue SUPPL. 1, 2006, Pages

  Schindler, Ralf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; ERYTHROPOIETIN; HEMOGLOBIN;

ARTICLE; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; DIALYSATE; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INFLAMMATION; KIDNEY FUNCTION; MEMBRANE PERMEABILITY; MORBIDITY; MORTALITY; QUALITY CONTROL; ULTRAFILTRATION;

BACTERIOLOGICAL TECHNIQUES; DNA, BACTERIAL; HEMODIALYSIS SOLUTIONS; HUMANS; INFLAMMATION;

EID: 33144460034     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2006.01193.x     Document Type: Article

References (24)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105:1135-1142.
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32:S112-S119.
3. Bologa RM, Levine DM, Parker TS, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis. 1998; 32:107-114.
4. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wannet C. Inflammation enhances cardiovascular risk and mortality in hemodialysis. Kidney Int. 1999; 55:648-658.
5. Laude-Sharp M, Haeffner CN, Caroff M, Lantreibecq F, Pusineri C, Kazatchkine MD. Dissociation between the interleukin 1-inducing capacity and Limulus reactivity of lipopolysaccharides from gram-negative bacteria. Cytokine. 1990; 2:253-258.
6. Krautzig S, Linnenweber S, Schindler R, Shaldon S, Koch KM, Lonnemann G. New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients. Nephrol Dial Transplant. 1996; 2:87-91.
7. Lonnemann G, Schindler R, Lufft V, Mahiout A, Shaldon S, Koch KM. The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes. Nephrol Dial Transplant. 1995; 10:207-211.
8. Pass T, Wright R, Sharp B, Harding GB. Culture of dialysis fluids on nutrient-rich media for short periods at elevated temperatures underestimate microbial contamination. Blood Purif. 1996; 14:136-145.
9. AAMI: ANSI/AAMI RD 52: Association for the advancement of medical instrumentation, in American National Standard: Dialysate for hemodialysis, Arlington, VA, 2004.
10. Schindler R, Beck W, Deppisch R, Aussieker M, Wilde A, Gohl H, Frei U. Short bacterial DNA fragments: Detection in dialysate and induction of cytokines. J Am Soc Nephrol. 2004; 15:3207-3214.
11. Stacey KJ, Sweet MJ, Hume DA. Macrophages ingest and are activated by bacterial DNA. J Immunol. 1996; 157:2116-2122.
12. Krieg AM. CpG DNA: Trigger of sepsis, mediator of protection, or both? Scan J Infect Dis. 2003; 35:653-659.
13. Hemmi H, Takeuchi O, Kawai T, et al. A toll-like receptor recognizes bacterial DNA. Nature. 2000; 408:740-745.
14. Lonnemann G, Behme TC, Lenzner B, et al. Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria. Kidney Int. 1992; 42: 61-68.
15. Pereira BJ, Snodgrass BR, Hogan PJ, King AJ. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes. Kidney Int. 1995; 47:603-610.
16. Schindler R, Krautzig S, Lufft V, et al. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood. Nephrol Dial Transplant. 1996; 11:101-108.
17. Schindler R, Dinarello CA. A method for removing interleukin-1- and tumor necrosis factor-inducing substances from bacterial cultures by ultrafiltration with polysulfone. J Immunol Methods. 1989; 116:159-165.
18. Schindler R, Christ-Kohlrausch F, Frei U, Shaldon S. Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogens. Clin Nephrol. 2003; 59: 447-454.
19. Schindler R, Lonnemann G, Schäffer J, Shaldon S, Koch KM, Krautzig S. The effect of ultrafiltered dialysate on the cellular content of Interleukin-1 receptor antagonist in patients on chronic hemodialysis. Nephron. 1994; 68:229-233.
20. Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant. 2000; 15:1207-1211.
21. Arizono K, Nomura K, Motoyama T, et al. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis. Blood Purif. 2004; 22(Suppl 2):26-29.
22. Izuhara Y, Miyata T, Saito K, et al. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress." Am J Kidney Dis. 2004; 43:1024-1029.
23. Rahmati MA, Homel P, Hoenich NA, Levin R, Kaysen GA, Levin NW. The role of improved water quality on inflammatory markers in patients undergoing regular dialysis. Int J Artif Organs. 2004; 27:723-727.
24. Hsu PY, Lin CL, Yu CC, et al. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study. J Nephrol. 2004; 17:693-700.